Manteia Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
30
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$15.5M
- Investors
-
5
Manteia General Information
Description
Developer of radiotherapy treatment system intended to cure cancer. The company utilizes advanced artificial intelligence and big data technologies to develop automatic target volume delineation software, dose calculation and evaluation system, remote cloud system and intelligent adaptive radiotherapy system, enabling patients with safe, accurate and efficient cancer treatment .
Contact Information
Website
www.manteiatech.comCorporate Office
- 19th Floor, Zhonghang Zijin Plaza
- No. 1811 Huandao East Road, Siming District
- Xiamen, Fujian
- China
Corporate Office
- 19th Floor, Zhonghang Zijin Plaza
- No. 1811 Huandao East Road, Siming District
- Xiamen, Fujian
- China
Manteia Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series B) | 18-Jan-2024 | $15.5M | Completed | Generating Revenue | ||
| 2. Early Stage VC (Series A) | 12-Jun-2020 | Completed | Generating Revenue | |||
| 1. Seed Round | 01-Apr-2018 | $5M | $5M | Completed | Startup |
Manteia Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Manteia Patents
Manteia Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4226970-A1 | Method and apparatus for adaptive radiation therapy based on plan library invoking | Active | 11-Feb-2022 | ||
| EP-4226970-B1 | Method and apparatus for adaptive radiation therapy based on plan library invoking | Active | 11-Feb-2022 | ||
| EP-4226970-C0 | Method and apparatus for adaptive radiation therapy based on plan library invoking | Active | 11-Feb-2022 | ||
| US-12217848-B2 | Method and apparatus for adaptive radiation therapy based on plan library invoking | Active | 11-Feb-2022 | ||
| US-20230260624-A1 | Method and apparatus for adaptive radiation therapy based on plan library invoking | Active | 11-Feb-2022 | G16H20/40 |
Manteia Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Manteia Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Haichuang Tiancheng | Growth/Expansion | Minority | ||
| Yangming Capital | Venture Capital | Minority | ||
| DYEE Capital | Asset Manager | Minority | ||
| Redhill Capital | Growth/Expansion | Minority | ||
| Fosun RZ Capital | Venture Capital | Minority |
Manteia FAQs
-
When was Manteia founded?
Manteia was founded in 2017.
-
Where is Manteia headquartered?
Manteia is headquartered in Xiamen, China.
-
What is the size of Manteia?
Manteia has 30 total employees.
-
What industry is Manteia in?
Manteia’s primary industry is Decision/Risk Analysis.
-
Is Manteia a private or public company?
Manteia is a Private company.
-
What is Manteia’s current revenue?
The current revenue for Manteia is .
-
How much funding has Manteia raised over time?
Manteia has raised $34.5M.
-
Who are Manteia’s investors?
Haichuang Tiancheng, Yangming Capital, DYEE Capital, Redhill Capital, and Fosun RZ Capital have invested in Manteia.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
